Validation Of The Prima-Prognostic Index For Patients Treated With Rituximab Plus Chemotherapy And Refinement Of Prognostic Parameters For Patients On Rituximab Plus Lenalidomide In The Phase Iii Relevance TrialEdith Julia,Nathan H Fowler,Emmanuel Bachy,Pierre Feugier,Reda Bouabdallah,Herve Tilly,M. Lia Palomba,Christophe Fruchart,Edward N. Libby,Rene-Olivier Casasnovas,Ian W. Flinn,Corinne Haioun,Herve Maisonneuve,Loic Ysebaert,Nancy L. Bartlett,Kamal Bouabdallah,Pauline Brice,Vincent Ribrag,Nicolas Daguindau,Steven Le Gouill,Gian-Matteo Pica,Alejandro Martín,Armando Lopez-Guillermo,Jean-Francois Larouche,Kiyoshi Ando,Gomes da Silva Maria,Marc André,Ka Lung Wu,Laurie H Sehn,Kensei Tobinai,Guillaume Cartron,Richard Delarue,Myron Czuczman,Luc Xerri,Gilles A. Salles,Franck MorschhauserBLOOD(2019)引用 3|浏览98暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要